Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by famaron Aug 02, 2020 9:02pm

232 Views

Post# 31356492

RE:Conference Call August 4th

...what's new to talk about other than they're financially ok due to ATM and they're started IRENE. or things are looking good with the other trials which are in progress. Then a few shareholders don't hear anything about partnership going forward and boom blood on the streets. Yes, it getting a bit boring here but these trials do take time because it's a persons life at stake here. A little surprize can go a long way to take us back to the $5.00 range now that we're further into the trials.

GLTA....fmb

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season